Skip to results
1-2 of 2
Authors: Shaily Arora
Sort by
Journal Article
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastatic Castrate‐Resistant Prostate Cancer Free
Mitchell S. Anscher and others
The Oncologist, Volume 26, Issue 2, February 2021, Pages 139–146, https://doi.org/10.1002/onco.13585
Published: 17 November 2020
Journal Article
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer Free
Shaily Arora and others
The Oncologist, Volume 26, Issue 1, January 2021, Pages e164–e172, https://doi.org/10.1002/onco.13551
Published: 20 October 2020
Advertisement
Advertisement